Literature DB >> 8380956

Detection of thrombomodulin in human lung cancer cells.

A Tamura1, O Matsubara, K Hirokawa, N Aoki.   

Abstract

Thrombomodulin (TM), which usually exists in vascular endothelial cells and exerts an anticoagulant activity, was detected by Western blot analyses and immunocytochemical staining using three anti-TM monoclonal antibodies in cultured cell lines derived from a squamous cell carcinoma and an adenocarcinoma of the lung, but was not detected in a cell line derived from a small cell carcinoma. Functional assays indicated that TM detected in these cells was functionally active. The presence of TM in 22 specimens of surgically removed lung cancer tissue was also examined by an immunohistochemical method. TM was present along the cell membranes in 4 (36%) of 11 squamous cell carcinomas examined, but was not detected in 10 adenocarcinomas and 1 large cell carcinoma examined. Because TM is identical to fetomodulin, which modulates embryogenesis, the authors have concluded that TM is an oncodevelopmental antigen. The authors have also suggested that functionally active TM on lung cancer cells may modulate cancer cell behaviors in such ways as exhibiting anticoagulant activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380956      PMCID: PMC1886825     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Spectrum of lung cancer and ectopic hormones.

Authors:  R Yesner
Journal:  Pathol Annu       Date:  1978

Review 2.  Desmosomal proteins: new markers for identification and classification of tumors.

Authors:  R Moll; P Cowin; H P Kapprell; W W Franke
Journal:  Lab Invest       Date:  1986-01       Impact factor: 5.662

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.

Authors:  N L Esmon; W G Owen; C T Esmon
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

6.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Characterization of the platelet-aggregating activity of tumor cells.

Authors:  Y Hara; M Steiner; M G Baldini
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

8.  A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1.

Authors:  R Kannagi; E Nudelman; S B Levery; S Hakomori
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Authors:  E Pearlstein; C Ambrogio; G Gasic; S Karpatkin
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  W G Owen; C T Esmon
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

View more
  6 in total

1.  Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.

Authors:  M W Boehme; Y Deng; U Raeth; A Bierhaus; R Ziegler; W Stremmel; P P Nawroth
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

2.  Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

Authors:  Y Zhang; H Weiler-Guettler; J Chen; O Wilhelm; Y Deng; F Qiu; K Nakagawa; M Klevesath; S Wilhelm; H Böhrer; M Nakagawa; H Graeff; E Martin; D M Stern; R D Rosenberg; R Ziegler; P P Nawroth
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

3.  Cellular localization of thrombomodulin in human epithelium and squamous malignancies.

Authors:  D J Lager; E J Callaghan; S F Worth; T J Raife; S R Lentz
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma.

Authors:  Toshihide Nishimura; Haruhiko Nakamura; Ayako Yachie; Takeshi Hase; Kiyonaga Fujii; Hirotaka Koizumi; Saeko Naruki; Masayuki Takagi; Yukiko Matsuoka; Naoki Furuya; Harubumi Kato; Hisashi Saji
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

5.  Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells.

Authors:  T Oikawa; M Kushuhara; S Ishikawa; J Hitomi; A Kono; T Iwanaga; K Yamaguchi
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

6.  Thrombomodulin expression impacts the recurrence and long-term survival in pancreatic cancer.

Authors:  Hiroshi Sugano; Yoshihiro Shirai; Shun Sato; Shigeharu Hamatani; Ryoga Hamura; Tomohiko Taniai; Takashi Horiuchi; Takeshi Gocho; Ken Eto; Toru Ikegami
Journal:  Ann Gastroenterol Surg       Date:  2021-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.